Cargando…
Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation
The identification of targeted agents with high therapeutic index is a major challenge for cancer drug discovery. We found that screening chemical libraries across neuroblastoma (NBL) tumor subtypes for selectively-lethal compounds revealed metabolic dependencies that defined each subtype. Bioactive...
Autores principales: | Stokes, Michael E., Small, Jonnell Candice, Vasciaveo, Alessandro, Shimada, Kenichi, Hirschhorn, Tal, Califano, Andrea, Stockwell, Brent R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329873/ https://www.ncbi.nlm.nih.gov/pubmed/32612149 http://dx.doi.org/10.1038/s41598-020-67310-0 |
Ejemplares similares
-
Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab
Geranylgeranyl
Transferase
por: Baron, Rudi A., et al.
Publicado: (2009) -
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
A quantitative method to measure geranylgeranyl diphosphate (GGPP) and geranylgeranyl monophosphate (GGP) in tomato (Solanum lycopersicum) fruit
por: Zita, Wayne, et al.
Publicado: (2023) -
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma, Shizhan, et al.
Publicado: (2019) -
Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016)